abstract |
Abstract Provided are pharmaceutical compositions comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4 (methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid, methods of treatment using such compositions, and their use in the manufacture of medicaments. - 64 - |